Description:
This was a cross-sectional study which estimated the patient and provider costs of BPaL compared to current standard-of-care treatment in the Philippines.
Start Date: October 22, 2022
Abstract:
Patients on BPaL under operational research, or 9 to 11-month Standard Short Oral Regimen (SSOR)
And 18 to 21-month Standard Long Oral Regimen (SLOR) under programmatic conditions were interviewed using the WHO cross-sectional TB patient cost tool.
Provider costs were assessed through a bottom-up and top-down costing analysis.
To Participate in the study kindly reach us via: